GT200500215A - Amidas sustituidas de àcido tienopirrolcarboxìlico, amidas del àcido pirrolotiazolcarboxìlico y anàlogos relacionados como inhibidores de la epsilon caseìna quinasa i - Google Patents

Amidas sustituidas de àcido tienopirrolcarboxìlico, amidas del àcido pirrolotiazolcarboxìlico y anàlogos relacionados como inhibidores de la epsilon caseìna quinasa i

Info

Publication number
GT200500215A
GT200500215A GT200500215A GT200500215A GT200500215A GT 200500215 A GT200500215 A GT 200500215A GT 200500215 A GT200500215 A GT 200500215A GT 200500215 A GT200500215 A GT 200500215A GT 200500215 A GT200500215 A GT 200500215A
Authority
GT
Guatemala
Prior art keywords
acid
quinasa
inhibitors
tienopirrolcarboxylic
pirrolotiazolcarboxylic
Prior art date
Application number
GT200500215A
Other languages
English (en)
Spanish (es)
Inventor
David Marc Fink
Yulin Chiang
Nicola Dawn Collar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GT200500215A publication Critical patent/GT200500215A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Peptides Or Proteins (AREA)
GT200500215A 2004-08-19 2005-08-09 Amidas sustituidas de àcido tienopirrolcarboxìlico, amidas del àcido pirrolotiazolcarboxìlico y anàlogos relacionados como inhibidores de la epsilon caseìna quinasa i GT200500215A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60334704P 2004-08-19 2004-08-19

Publications (1)

Publication Number Publication Date
GT200500215A true GT200500215A (es) 2006-03-27

Family

ID=35695546

Family Applications (1)

Application Number Title Priority Date Filing Date
GT200500215A GT200500215A (es) 2004-08-19 2005-08-09 Amidas sustituidas de àcido tienopirrolcarboxìlico, amidas del àcido pirrolotiazolcarboxìlico y anàlogos relacionados como inhibidores de la epsilon caseìna quinasa i

Country Status (30)

Country Link
US (2) US7393867B2 (enExample)
EP (1) EP1784409B1 (enExample)
JP (1) JP4869232B2 (enExample)
KR (1) KR20070045263A (enExample)
CN (1) CN100562521C (enExample)
AR (1) AR051008A1 (enExample)
AT (1) ATE471326T1 (enExample)
AU (1) AU2005272584B2 (enExample)
BR (1) BRPI0514419A (enExample)
CA (1) CA2577879C (enExample)
CY (1) CY1110775T1 (enExample)
DE (1) DE602005021889D1 (enExample)
DK (1) DK1784409T3 (enExample)
ES (1) ES2347166T3 (enExample)
GT (1) GT200500215A (enExample)
HR (1) HRP20100475T1 (enExample)
IL (1) IL181158A0 (enExample)
JO (1) JO2629B1 (enExample)
MY (1) MY139831A (enExample)
PA (1) PA8642801A1 (enExample)
PE (1) PE20060630A1 (enExample)
PL (1) PL1784409T3 (enExample)
PT (1) PT1784409E (enExample)
RS (1) RS51413B (enExample)
RU (1) RU2403257C2 (enExample)
SI (1) SI1784409T1 (enExample)
SV (1) SV2006002190A (enExample)
TW (1) TWI372149B (enExample)
UY (1) UY29077A1 (enExample)
WO (1) WO2006021000A2 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ548212A (en) 2003-12-29 2010-07-30 Sepracor Inc Pyrrole and pyrazole DAAO inhibitors
US8053603B2 (en) 2006-01-06 2011-11-08 Sunovion Pharmaceuticals Inc. Tetralone-based monoamine reuptake inhibitors
KR101294014B1 (ko) 2006-01-06 2013-08-09 선오비온 파마슈티컬스 인코포레이티드 모노아민 재흡수 저해제로서의 시클로알킬아민
DK2816024T3 (en) 2006-03-31 2017-10-30 Sunovion Pharmaceuticals Inc CHIRALE AMINER
US7884124B2 (en) 2006-06-30 2011-02-08 Sepracor Inc. Fluoro-substituted inhibitors of D-amino acid oxidase
US7902252B2 (en) 2007-01-18 2011-03-08 Sepracor, Inc. Inhibitors of D-amino acid oxidase
EP1955699A1 (en) * 2007-02-08 2008-08-13 Boehringer Ingelheim Pharma GmbH & Co. KG Use of flibanserin for the treatment of insomnia
MX2009012685A (es) 2007-05-31 2009-12-14 Sepracor Inc Cicloalquilaminas sustituidas con fenilo como inhibidores de la reabsorcion de monoamina.
JP4748823B2 (ja) * 2009-02-12 2011-08-17 株式会社ファルマデザイン カゼインキナーゼ1δ及びカゼインキナーゼ1ε阻害剤
UA106082C2 (uk) * 2009-05-28 2014-07-25 Вертекс Фармасьютікалз Інкорпорейтед АМІНОПІРАЗОЛ ТРИАЗОЛОТІАДІАЗОЛЬНІ ІНГІБІТОРИ ПРОТЕЇНКІНАЗИ c-МЕТ
MX2012004997A (es) * 2009-10-28 2012-06-12 Pfizer Derivados de imidazol como inhibidores de la caseina quinasa.
DE102009058280A1 (de) * 2009-12-14 2011-06-16 Merck Patent Gmbh Thiazolderivate
CN104803997A (zh) * 2010-08-09 2015-07-29 株式会社创药分子设计 酪蛋白激酶1δ及酪蛋白激酶1ε抑制剂
CN109748927A (zh) * 2017-11-03 2019-05-14 上海交通大学医学院附属瑞金医院 杂芳基酰胺类化合物、其制备方法、药用组合物及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9702001D0 (sv) * 1997-05-28 1997-05-28 Astra Pharma Prod Novel compounds
KR100722176B1 (ko) * 1999-06-08 2007-05-29 아벤티스 파마슈티칼스 인크. 일주기 리듬 단백질을 변화시키기 위한 스크리닝 방법
CN100439367C (zh) * 2003-12-11 2008-12-03 安万特药物公司 作为酪蛋白激酶Iε抑制剂的取代的1H-吡咯并[3,2-b、3,2-c和2,3-c]吡啶-2-甲酰胺以及相关类似物

Also Published As

Publication number Publication date
HK1105198A1 (en) 2008-02-06
PE20060630A1 (es) 2006-08-03
CN100562521C (zh) 2009-11-25
BRPI0514419A (pt) 2008-06-10
AR051008A1 (es) 2006-12-13
JP4869232B2 (ja) 2012-02-08
US7393867B2 (en) 2008-07-01
RS51413B (sr) 2011-02-28
PA8642801A1 (es) 2006-05-16
JP2008510712A (ja) 2008-04-10
ES2347166T3 (es) 2010-10-26
DE602005021889D1 (en) 2010-07-29
JO2629B1 (en) 2012-06-24
RU2007109812A (ru) 2008-09-27
CY1110775T1 (el) 2015-06-10
WO2006021000A2 (en) 2006-02-23
US20070299112A1 (en) 2007-12-27
HRP20100475T1 (hr) 2010-10-31
AU2005272584A1 (en) 2006-02-23
US7652046B2 (en) 2010-01-26
CN101001861A (zh) 2007-07-18
TWI372149B (en) 2012-09-11
MY139831A (en) 2009-10-30
AU2005272584B2 (en) 2010-11-11
US20080227822A1 (en) 2008-09-18
PT1784409E (pt) 2010-09-06
ATE471326T1 (de) 2010-07-15
UY29077A1 (es) 2006-03-31
TW200621788A (en) 2006-07-01
SV2006002190A (es) 2006-05-24
KR20070045263A (ko) 2007-05-02
CA2577879C (en) 2011-07-12
SI1784409T1 (sl) 2010-10-29
WO2006021000A3 (en) 2006-06-15
IL181158A0 (en) 2007-07-04
RU2403257C2 (ru) 2010-11-10
EP1784409A2 (en) 2007-05-16
CA2577879A1 (en) 2006-02-23
PL1784409T3 (pl) 2010-10-29
DK1784409T3 (da) 2010-09-27
EP1784409B1 (en) 2010-06-16

Similar Documents

Publication Publication Date Title
GT200600197A (es) Compuestos y composiciones como inhibidores de proteina quinasa
GT200800184A (es) Aminotetrahidropiranos como inhibidores de dipeptidil peptidasa-iv para el tratamiento o prevencion de diabetes.
GT200600205A (es) Nuevos herbicidas
BRPI0512683A (pt) compostos anti-virais
GT200800258A (es) Compuestos de pirrolo-pirimidina y sus usos
GT200600159A (es) Derivados benzodioxano y benzodioxolano y usos de los mismos
GT200500208A (es) Indazoles ùtiles para tratar enfermedades cardiovasculares
ECSP078060A (es) 2,4-diamino-pirimidinas como inhibidores de aurora
DOP2006000169A (es) Inhibidores espiropiperidina de beta-secretasa para el tratamiento de la enfermedad de alzheimer
CR9493A (es) Heteroarilamidas (3.1.0)biciclicas como inhibidores del transporte de glicina de tipo i
GT200300219A (es) Compuestos de tiazol para el tratamiento de trastornos neurodegenerativos
ECSP12011880A (es) INHIBIDORES DE N1-PIRAZOLOESPIROCETONA ACETIL-CoA CARBOXILASA
UY32098A (es) Heteroarilos sustituidos
ECSP11011044A (es) Aminotetrahidropiranos como inhibidores de dipeptidil peptidasa-iv para el tratamiento o prevención de diabetes
CR7643A (es) Derivados de 1-heterociclialquil -3-sulfonilazaindol o azaindazol como ligandos de 5-hidroxitriptamina-6
GT200600167A (es) Derivados de dihidrobenzofurano y usos de los mismos
GT200500097A (es) Compuestos de morfolina sustituida para el tratamiento de trastornos del sistema nervioso central
GT200300033A (es) Derivados de nicotinamida utiles como inhibidores de pde4
CR10060A (es) 3-aminociclopentanocarboxamidas como moduladores de receptores de quimioquinas
UY31803A (es) Compuesto cristalino
GT200600174A (es) Pirrolopiridinas sustituidas, composiciones que las contienen, proceso de fabricacion y utilizacion
CO6321241A2 (es) Derivados de 1,3,4- tiadiazol espiro condensados para la inhibicion de la actividad de quinesina (ksp)
EA200700909A1 (ru) Азаиндолкарбоксамиды
GT200500292A (es) Derivados de 2-amido-4-feniltiazol, su preparacion y su aplicacion en terapeutica
GT200400041A (es) Derivados azabiciclicos de piridiloximetilo y bencisoxazol